Researchers at our Orange County laboratory in California, USA, engage in new product development based on core competencies in chemistry and our many proprietary, patent-rich manufacturing processes.

The Orange County facility has been the home for CDI™ optical fluorescence and other sensing technologies for more than twenty years. Engineers there pioneered the concept of continuous blood parameter monitoring in cardiac surgery, allowing heart teams access to real-time data that has been proven to positively affect patient outcomes.

Our blood parameter monitoring systems are the most widely used continuous monitoring devices for cardiac surgery in the world. The CDI™ Blood Parameter Monitoring System 500 quickly established the accuracy and reliability of its results and many leading perfusionists have adopted it as their standard of care in the conduct of cardiopulmonary bypass.

Click here to go to the Terumo Cardiovascular Systems eCatalog for more information on intraoperative monitoring devices.